{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:02:32Z","timestamp":1762459352482,"version":"3.41.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["contemporaryclinicaltrials.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.cct.2016.02.008","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T08:54:40Z","timestamp":1456908880000},"page":"334-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Design considerations for a pilot trial using a novel approach for evaluating smoking-cessation medication in methadone-maintained smokers"],"prefix":"10.1016","volume":"47","author":[{"given":"Theresa","family":"Winhusen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Theobald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2016.02.008_bb0005","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMsa1407211","article-title":"Smoking and mortality\u2014beyond established causes","volume":"372","author":"Carter","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2016.02.008_bb0010","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.15585\/mmwr.mm6444a2","article-title":"Current cigarette smoking among adults \u2014 United States, 2005\u20132014","volume":"64","author":"Jamal","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.cct.2016.02.008_bb0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/ntr\/ntr048","article-title":"Smoking prevalence in addiction treatment: a review","volume":"13","author":"Guydish","year":"2011","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.cct.2016.02.008_bb0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0376-8716(96)01331-2","article-title":"Smoking habits and attitudes in a methadone maintenance treatment population","volume":"44","author":"Clemmey","year":"1997","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2016.02.008_bb0025","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2105\/AJPH.91.2.296","article-title":"Tobacco use and quit attempts among methadone maintenance clients","volume":"91","author":"Richter","year":"2001","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.cct.2016.02.008_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1300\/J069v17n02_02","article-title":"Interest in smoking cessation among methadone maintained outpatients","volume":"17","author":"Frosch","year":"1998","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.cct.2016.02.008_bb0035","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jsat.2013.07.009","article-title":"Characterizing smoking, cessation services, and quit interest across outpatient substance abuse treatment modalities","volume":"46","author":"McClure","year":"2014","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.cct.2016.02.008_bb0040","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/ntr\/ntv030","article-title":"Are pharmacotherapies ineffective in opioid-dependent smokers? Reflections on the scientific literature and future directions","volume":"17","author":"Miller","year":"2015","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.cct.2016.02.008_bb0045","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/ntr\/ntu099","article-title":"Early quit days among methadone-maintained smokers in a smoking cessation trial","volume":"16","author":"de Dios","year":"2014","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.cct.2016.02.008_bb0050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jsat.2007.08.010","article-title":"Smoking cessation treatment in community-based substance abuse rehabilitation programs","volume":"35","author":"Reid","year":"2008","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.cct.2016.02.008_bb0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/1874473711306010009","article-title":"Cigarette smoking in methadone maintained patients: an up-to-date review","volume":"6","author":"Zirakzadeh","year":"2013","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.cct.2016.02.008_bb0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jsat.2009.10.001","article-title":"Smoking cessation interventions among individuals in methadone maintenance: a brief review","volume":"38","author":"Okoli","year":"2010","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.cct.2016.02.008_bb0065","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/add.12631","article-title":"Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial","volume":"109","author":"Nahvi","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.cct.2016.02.008_bb0070","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.drugalcdep.2013.07.005","article-title":"Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial","volume":"133","author":"Stein","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2016.02.008_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-013-3364-6","article-title":"An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation","volume":"231","author":"Perkins","year":"2014","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.cct.2016.02.008_bb0080","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/ntr\/nts090","article-title":"Developing and validating a human laboratory model to screen medications for smoking cessation","volume":"14","author":"McKee","year":"2012","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.cct.2016.02.008_bb0085","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMsb1503104","article-title":"Precision medicine\u2014personalized, problematic, and promising","volume":"372","author":"Jameson","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2016.02.008_bb0090","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0022-3565(25)21845-6","article-title":"Effects of methadone on human cigarette-smoking and subjective ratings","volume":"229","author":"Chait","year":"1984","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cct.2016.02.008_bb0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0376-8716(94)90162-7","article-title":"The effects of high and low-doses of methadone on cigarette-smoking","volume":"34","author":"Schmitz","year":"1994","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2016.02.008_bb0100","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF00427902","article-title":"Buprenorphine effects on cigarette-smoking","volume":"86","author":"Mello","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.cct.2016.02.008_bb0105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/14622200210124012","article-title":"An inpatient study of the effects of buprenorphine on cigarette smoking in men concurrently dependent on cocaine and opioids","volume":"4","author":"Mutschler","year":"2002","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.cct.2016.02.008_bb0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00427594","article-title":"Effects of heroin self-administration on cigarette smoking","volume":"67","author":"Mello","year":"1980","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.cct.2016.02.008_bb0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/JCP.0b013e3181a39113","article-title":"Methadone\u2013nicotine interactions in methadone maintenance treatment patients","volume":"29","author":"Elkader","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.cct.2016.02.008_bb0120","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-004-2020-6","article-title":"Methadone and nicotine self-administration in humans: a behavioral economic analysis","volume":"178","author":"Spiga","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.cct.2016.02.008_bb0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0740-5472(03)00065-5","article-title":"Why do so many drug users smoke?","volume":"25","author":"McCool","year":"2003","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.cct.2016.02.008_bb0130","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1037\/1064-1297.15.2.144","article-title":"Patterns of smoking and methadone dose in drug treatment patients","volume":"15","author":"Richter","year":"2007","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.cct.2016.02.008_bb0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1037\/1064-1297.15.1.67","article-title":"Daily smoking patterns, their determinants, and implications for quitting","volume":"15","author":"Chandra","year":"2007","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.cct.2016.02.008_bb0140","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMp1011512","article-title":"A flood of opioids, a rising tide of deaths","volume":"363","author":"Okie","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2016.02.008_bb0145","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2016.02.008_bb0150","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJM199511023331807","article-title":"Nicotine medications for smoking cessation","volume":"333","author":"Henningfield","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2016.02.008_bb0155","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/BF00314989","article-title":"Absolute bioavailability of nicotine applied to different nasal regions","volume":"41","author":"Johansson","year":"1991","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.cct.2016.02.008_bb0160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation \u2014 a randomized controlled trial","volume":"296","author":"Gonzales","year":"2006","journal-title":"Jama-J. Am. Med. Assoc."},{"key":"10.1016\/j.cct.2016.02.008_bb0165","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation \u2014 a randomized controlled trial","volume":"296","author":"Jorenby","year":"2006","journal-title":"JAMA-J. Am. Med. Assoc."},{"key":"10.1016\/j.cct.2016.02.008_bb0170","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00213-010-2101-7","article-title":"Alpha7 nicotinic acetylcholine receptors in the central amygdaloid nucleus alter naloxone-induced withdrawal following a single exposure to morphine","volume":"214","author":"Ishida","year":"2011","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.cct.2016.02.008_bb0175","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejphar.2005.06.050","article-title":"Effects of alpha4beta2 and alpha7 nicotinic acetylcholine receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats","volume":"519","author":"Motoshima","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cct.2016.02.008_bb0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.addbeh.2014.11.007","article-title":"Varenicline for opioid withdrawal in patients with chronic pain: a randomized, single-blinded, placebo controlled pilot trial","volume":"42","author":"Hooten","year":"2015","journal-title":"Addict. Behav."},{"key":"10.1016\/j.cct.2016.02.008_bb0185","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1037\/0022-006X.68.1.134","article-title":"The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties","volume":"68","author":"Fals-Stewart","year":"2000","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.cct.2016.02.008_bb0190","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","article-title":"Signs and symptoms of tobacco withdrawal","volume":"43","author":"Hughes","year":"1986","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.cct.2016.02.008_bb0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/00952998709001515","article-title":"Two new rating scales for opiate withdrawal","volume":"13","author":"Handelsman","year":"1987","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.cct.2016.02.008_bb0200","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00213-012-2954-z","article-title":"The drug effects questionnaire: psychometric support across three drug types","volume":"227","author":"Morean","year":"2013","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.cct.2016.02.008_bb0205","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s002130000382","article-title":"A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler","volume":"149","author":"West","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.cct.2016.02.008_bb0210","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2147\/COPD.S1848","article-title":"Smoking cessation therapy with varenicline","volume":"3","author":"Mohanasundaram","year":"2008","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714416300222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714416300222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T15:58:24Z","timestamp":1748793504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714416300222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":42,"alternative-id":["S1551714416300222"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2016.02.008","relation":{},"ISSN":["1551-7144"],"issn-type":[{"type":"print","value":"1551-7144"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design considerations for a pilot trial using a novel approach for evaluating smoking-cessation medication in methadone-maintained smokers","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2016.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}